On Tuesday, Jasper Therapeutics Inc (NASDAQ: JSPR) opened lower -5.24% from the last session, before settling in for the closing price of $1.91. Price fluctuations for JSPR have ranged from $1.39 to $22.99 over the past 52 weeks.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 54.53%. Company’s average yearly earnings per share was noted 11.63% at the time writing. With a float of $23.87 million, this company’s outstanding shares have now reached $27.98 million.
Considering the fact that the conglomerate employs 64 people, you should pay attention to its efficiency factor.
Jasper Therapeutics Inc (JSPR) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Jasper Therapeutics Inc is 14.71%, while institutional ownership is 59.97%. The most recent insider transaction that took place on Sep 22 ’25, was worth 99,630. In this transaction Director of this company bought 41,000 shares at a rate of $2.43, taking the stock ownership to the 41,000 shares. Before that another transaction happened on Sep 22 ’25, when Company’s Director bought 20,000 for $2.43, making the entire transaction worth $48,600. This insider now owns 20,000 shares in total.
Jasper Therapeutics Inc (JSPR) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -1.62 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -1.23) by -0.39. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.68 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.63% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 23.18% during the next five years compared to 54.53% growth over the previous five years of trading.
Jasper Therapeutics Inc (NASDAQ: JSPR) Trading Performance Indicators
Check out the current performance indicators for Jasper Therapeutics Inc (JSPR). In the past quarter, the stock posted a quick ratio of 2.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.90, a number that is poised to hit -0.72 in the next quarter and is forecasted to reach -2.61 in one year’s time.
Technical Analysis of Jasper Therapeutics Inc (JSPR)
Compared to the last year’s volume of 0.75 million, its volume of 1.06 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 71.83%.
During the past 100 days, Jasper Therapeutics Inc’s (JSPR) raw stochastic average was set at 24.00%, which indicates a significant decrease from 59.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1456 in the past 14 days, which was lower than the 0.1712 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.9535, while its 200-day Moving Average is $3.4777. Nevertheless, the first resistance level for the watch stands at $1.8633 in the near term. At $1.9167, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.9433. If the price goes on to break the first support level at $1.7833, it is likely to go to the next support level at $1.7567. Should the price break the second support level, the third support level stands at $1.7033.
Jasper Therapeutics Inc (NASDAQ: JSPR) Key Stats
There are currently 27,984K shares outstanding in the company with a market cap of 50.65 million. Presently, the company’s annual sales total 0 K according to its annual income of -71,270 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -18,740 K.
